Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
UTHR [NASD]
United Therapeutics Corporation
Index- P/E20.69 EPS (ttm)4.51 Insider Own0.10% Shs Outstand47.97M Perf Week-0.52%
Market Cap4.48B Forward P/E10.82 EPS next Y8.62 Insider Trans-3.22% Shs Float47.16M Perf Month5.42%
Income249.80M PEG4.14 EPS next Q1.75 Inst Own96.90% Short Float10.64% Perf Quarter-6.72%
Sales1.16B P/S3.85 EPS this Y-42.60% Inst Trans-1.38% Short Ratio6.69 Perf Half Y-11.68%
Book/sh26.94 P/B3.46 EPS next Y10.57% ROA12.60% Target Price104.43 Perf Year26.49%
Cash/sh15.85 P/C5.88 EPS next 5Y5.00% ROE19.30% 52W Range70.34 - 116.65 Perf YTD-17.50%
Dividend- P/FCF11.42 EPS past 5Y38.20% ROI11.80% 52W High-20.03% Beta1.33
Dividend %- Quick Ratio1.40 Sales past 5Y31.70% Gross Margin88.60% 52W Low32.63% ATR3.53
Employees706 Current Ratio1.50 Sales Q/Q18.10% Oper. Margin35.70% RSI (14)51.60 Volatility5.11% 3.29%
OptionableYes Debt/Eq0.21 EPS Q/Q104.20% Profit Margin21.50% Rel Volume1.64 Prev Close98.21
ShortableYes LT Debt/Eq0.00 EarningsJul 29 BMO Payout0.00% Avg Volume749.83K Price93.29
Recom2.40 SMA201.16% SMA500.19% SMA200-3.07% Volume1,229,184 Change-5.01%
30-Jul-14Reiterated H.C. Wainwright Buy $120 → $150
07-Apr-14Upgrade Standpoint Research Hold → Buy $118
26-Feb-14Reiterated RBC Capital Mkts Sector Perform $80 → $90
26-Feb-14Reiterated Ladenburg Thalmann Buy $138 → $135
31-Dec-13Reiterated Argus Buy $120 → $130
23-Dec-13Upgrade Ladenburg Thalmann Neutral → Buy $138
02-Dec-13Reiterated Argus Buy $85 → $110
05-Aug-13Reiterated Argus Buy $75 → $85
30-Jul-13Downgrade Standpoint Research Buy → Hold
20-Jun-13Upgrade Standpoint Research Hold → Buy
15-May-13Downgrade Standpoint Research Buy → Hold
25-Mar-13Reiterated Ladenburg Thalmann Buy $69 → $63
27-Feb-13Reiterated RBC Capital Mkts Sector Perform $45 → $50
03-Aug-12Downgrade Standpoint Research Buy → Hold
27-Apr-12Downgrade Canaccord Genuity Buy → Hold
26-Mar-12Initiated Canaccord Genuity Buy $56
12-Mar-12Initiated Standpoint Research Buy $65
14-Feb-12Reiterated Brean Murray Buy $55 → $57
25-Aug-11Reiterated Oppenheimer Outperform $77 → $53
25-Aug-11Downgrade Maxim Group Buy → Hold
30-Jul-14 10:56AM  Perilous Reversal Watch: United Therapeutics (UTHR) at TheStreet -5.01%
07:08AM  United Therapeutics (UTHR) Jumps: Stock Adds 8.1% in Session Zacks
29-Jul-14 07:07AM  Q2 2014 United Therapeutics Earnings Release - Before Market Open CCBN +8.10%
06:03AM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
06:03AM  UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  United Therapeutics Corporation Reports Second Quarter 2014 Financial Results PR Newswire
22-Jul-14 06:00AM  United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014 PR Newswire
10-Jul-14 03:43PM  Supernus Up on Non-Dilutive Royalty Deal Zacks
09-Jul-14 05:00PM  Pluristem Initiates Trial in South Korea Zacks
08-Jul-14 07:30AM  Supernus to Receive $30 Million in Non-Dilutive Royalty Deal GlobeNewswire
05:47AM  United Therapeutics draws bulls optionMONSTER
27-Jun-14 09:14AM  Today's Top Biotech Stocks: Bristol-Myers Squibb, United Therapeutics and Vertex Pharmaceuticals at Motley Fool
09:14AM  Today's Top Biotech Stocks: Bristol-Myers Squibb, United Therapeutics and Vertex Pharmaceuticals
06:02AM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc EDGAR Online
06:02AM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc
06:00AM  United Therapeutics Announces Additional $500 Million Share Repurchase Program PR Newswire
06:00AM  United Therapeutics Announces Additional $500 Million Share Repurchase Program
19-Jun-14 01:18PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into United Therapeutics Corporation Regarding Possible Breaches of Fiduciary Duty Business Wire
01:18PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into United Therapeutics Corporation Regarding Possible Breaches of Fiduciary Duty
16-Jun-14 09:49AM  United Therapeutics (UTHR) Marked As A Dead Cat Bounce Stock at TheStreet
09:49AM  United Therapeutics (UTHR) Marked As A Dead Cat Bounce Stock
07:26AM  Weakness Seen in United Therapeutics (UTHR): Stock Tumbles 8.0% Zacks
07:26AM  Weakness Seen in United Therapeutics (UTHR): Stock Tumbles 8.0%
13-Jun-14 04:46PM  Can Pig Lungs Keep Growth Flying for United Therapeutics Shareholders? at Motley Fool -7.97%
04:46PM  Can Pig Lungs Keep Growth Flying for United Therapeutics Shareholders?
09-Jun-14 02:34PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into United Therapeutics Corporation Regarding Possible Breaches of Fiduciary Duty PR Newswire
02:34PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into United Therapeutics Corporation Regarding Possible Breaches of Fiduciary Duty
21-May-14 05:34PM  [video] Momentum trades alive: ARCB, UTHR at CNBC
05:34PM  [video] Momentum trades alive: ARCB, UTHR
20-May-14 05:00PM  Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM) GlobeNewswire
05:00PM  Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM)
11:19AM  Why I'm Long Supernus, A Small Specialty Pharma Company at Seeking Alpha
13-May-14 11:12AM  3 picks for bent but not broken biotech Breakout
11-May-14 05:45AM  Industry Ranks May 2014 at Seeking Alpha
05:45AM  Industry Ranks May 2014
08-May-14 12:16PM  Insider Trading Alert - K, EQR And UTHR Traded By Insiders at TheStreet
12:16PM  Insider Trading Alert - K, EQR And UTHR Traded By Insiders
06-May-14 06:07AM  Pig organ transplants to humans move a step closer at Financial Times
06:00AM  Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field PR Newswire
06:00AM  Genome scientist Craig Venter in deal to make humanized pig organs Reuters
06:00AM  Genome scientist Craig Venter in deal to make humanized pig organs
05-May-14 06:32PM  3 Biotech Stocks Making Big Moves Last Week at Motley Fool
03-May-14 01:04PM  UNITED THERAPEUTICS CORP Financials EDGAR Online Financials
01-May-14 12:10PM  United Therapeutics Gains on Q1 Earnings Zacks
29-Apr-14 06:00PM  United Therapeutics Management Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha +6.13%
07:07AM  Q1 2014 United Therapeutics Earnings Release - Before Market Open CCBN
06:04AM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
06:04AM  UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  United Therapeutics Corporation Reports First Quarter 2014 Financial Results PR Newswire
22-Apr-14 06:00AM  United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014 PR Newswire
07-Apr-14 11:16AM  United Therapeutics upgraded by Standpoint Research Briefing.com
01-Apr-14 04:03AM  United Therapeutics: 7 Different Insiders Have Sold Shares This Month at Seeking Alpha
26-Mar-14 05:33PM  [video] The false temptation of growth at CNBC
09:13AM  Todays Top Biotech Stories: Insmed, Exelixis, United Therapeutics, and Alnylam at Motley Fool
06:00AM  Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin PR Newswire
18-Mar-14 04:31PM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
16-Mar-14 05:16PM  Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook at Seeking Alpha
11-Mar-14 01:56PM  United Therapeutics retreats after FDA denies petition on Remodulin label at theflyonthewall.com
01:56PM  United Therapeutics retreats after FDA denies petition on Remodulin label
12:52PM  United Therapeutics: A Profitable Biotech With A Potentially Undervalued Pipeline at Seeking Alpha
12:52PM  United Therapeutics: A Profitable Biotech With A Potentially Undervalued Pipeline
12:24PM  United Therapeutics lower after FDA denies Remodulin citizen petition at theflyonthewall.com
12:24PM  United Therapeutics lower after FDA denies Remodulin citizen petition
28-Feb-14 01:04PM  UNITED THERAPEUTICS CORP Financials EDGAR Online Financials
27-Feb-14 08:10AM  United Therapeutics Slips on Q4 Earnings Report Zacks
08:10AM  United Therapeutics Slips on Q4 Earnings Report
26-Feb-14 09:26AM  Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls Zacks
09:26AM  Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls
25-Feb-14 06:18PM  Jazz Sings Blues On Q4 Sales, Earnings Investor's Business Daily
03:15PM  United Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
03:15PM  United Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript
12:17PM  United Therapeutics Q4 Revenue Misses, Stock Slides Optionetics
12:17PM  United Therapeutics Q4 Revenue Misses, Stock Slides at Investor's Business Daily
12:17PM  United Therapeutics Q4 Revenue Misses, Stock Slides
08:55AM  United Therapeutics Corporation Discusses Q4 2013 Results (Webcast) at Seeking Alpha
08:55AM  United Therapeutics Corporation Discusses Q4 2013 Results (Webcast)
07:07AM  Q4 2013 United Therapeutics Earnings Release - Before Market Open CCBN
06:11AM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
06:10AM  UNITED THERAPEUTICS CORP Files SEC form 10-K, Annual Report EDGAR Online
06:00AM  United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results PR Newswire
21-Feb-14 05:38AM  Cempra (CEMP) Jumps: Stock Adds 6.1% in Session Zacks
20-Feb-14 08:44AM  3 Biotech Stocks to Bet on this Earnings Season Zacks
18-Feb-14 06:00AM  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014 PR Newswire
31-Jan-14 05:11PM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure EDGAR Online
05:11PM  UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
11:48AM  [video] Pluristem CEO Seeing the Future in 3D Cells at TheStreet
11:48AM  [video] Pluristem CEO Seeing the Future in 3D Cells
28-Jan-14 04:50PM  Manufacturing Approval for Pluristem Facility Zacks
04:50PM  Manufacturing Approval for Pluristem Facility
10-Jan-14 06:52PM  Cramer's homework uncovers intriguing stock at CNBC
09-Jan-14 01:00PM  Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation on Behalf of its Shareholders - UTHR PR Newswire
01:00PM  Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation on Behalf of its Shareholders - UTHR
08-Jan-14 02:10PM  Chelsea's Northera Gets Another Chance at Motley Fool
02:10PM  Chelsea's Northera Gets Another Chance
07-Jan-14 11:20AM  Pluristem to Release Trial Results Zacks
11:20AM  Pluristem to Release Trial Results
03-Jan-14 12:34PM  Pluristem Touches 52-Week High Zacks
12:34PM  Pluristem Touches 52-Week High
06:51AM  The Zacks Analyst Blog Highlights: United Therapeutics, TESARO, Supernus, BioSpecifics Technologies and Medicines Co. Zacks
06:51AM  The Zacks Analyst Blog Highlights: United Therapeutics, TESARO, Supernus, BioSpecifics Technologies and Medicines Co.
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension (PAH). The company also provides Tyvaso, an inhaled prostacyclin therapy; and Adcirca, a once-daily oral therapy for the treatment of PAH. In addition, it develops Orenitram, a prostacyclin analog for treatment of PAH; Ch14.18 MAb, an antibody for the treatment of neuroblastoma; Beraprost 314d, which is under Phase III clinical trials for the treatment of PAH; and PLacental eXpanded cells that are under Phase I trial for the treatment of PAH. Further, the company is involved in the pre-clinical stage development of TransCon Treprostinil and TransCon Beraprost for the treatment of PAH; glycobiology antiviral agents for the treatment of infectious diseases; UV-4B, an antiviral alpha-glucosidase inhibitor for the treatment of dengue; and engineered lungs and lung tissue that can be transplanted into patients suffering from PAH and other lung diseases. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JEFFS ROGERPresident & COOJul 29Option Exercise30.7550,0001,537,50051,234Jul 29 06:03 PM
JEFFS ROGERPresident & COOJul 29Sale96.2550,0004,812,3291,234Jul 29 06:03 PM
ROTHBLATT MARTINE ACEOJul 24Option Exercise32.339,228298,3655,535Jul 25 07:20 PM
ROTHBLATT MARTINE ACEOJul 24Sale93.159,228859,544140Jul 25 07:20 PM
ROTHBLATT MARTINE ACEOJul 17Option Exercise34.563,833132,4683,973Jul 18 04:12 PM
Ferrari John MaximCFOJul 17Option Exercise50.0910,000500,90010,407Jul 22 08:52 AM
ROTHBLATT MARTINE ACEOJul 17Sale90.873,833348,291140Jul 18 04:12 PM
Ferrari John MaximCFOJul 17Sale89.7410,000897,400407Jul 22 08:52 AM
JEFFS ROGERPresident & COOJul 11Option Exercise30.7510,000307,50011,234Jul 14 04:49 PM
JEFFS ROGERPresident & COOJul 11Sale93.0610,000930,6211,234Jul 14 04:49 PM
ROTHBLATT MARTINE ACEOJul 10Option Exercise32.349,187297,1045,494Jul 11 04:52 PM
ROTHBLATT MARTINE ACEOJul 10Sale92.339,187848,226140Jul 11 04:52 PM
Ferrari John MaximCFOJul 03Option Exercise50.0910,000500,90010,407Jul 08 04:18 PM
Ferrari John MaximCFOJul 03Sale90.5810,000905,800407Jul 08 04:18 PM
ROTHBLATT MARTINE ACEOJun 26Option Exercise34.563,833132,4683,973Jun 27 04:43 PM
ROTHBLATT MARTINE ACEOJun 26Sale87.233,833334,340140Jun 27 04:43 PM
JEFFS ROGERPresident & COOJun 20Option Exercise30.7510,000307,50011,234Jun 23 04:17 PM
JEFFS ROGERPresident & COOJun 20Sale87.0010,000870,0001,234Jun 23 04:17 PM
Ferrari John MaximCFOJun 19Option Exercise50.0910,000500,90010,407Jun 23 04:16 PM
ROTHBLATT MARTINE ACEOJun 19Option Exercise34.563,833132,4683,973Jun 20 04:58 PM
MAHON PAUL AEVP & General CounselJun 19Option Exercise30.752,00061,50036,832Jun 20 05:00 PM
Ferrari John MaximCFOJun 19Sale87.0210,000870,200407Jun 23 04:16 PM
ROTHBLATT MARTINE ACEOJun 19Sale85.683,833328,429140Jun 20 04:58 PM
MAHON PAUL AEVP & General CounselJun 19Sale85.672,000171,34034,832Jun 20 05:00 PM
ROTHBLATT MARTINE ACEOJun 12Option Exercise32.369,066293,3835,373Jun 13 05:23 PM
ROTHBLATT MARTINE ACEOJun 12Sale98.229,066890,482140Jun 13 05:23 PM
JEFFS ROGERPresident & COOJun 10Option Exercise30.7510,000307,50011,234Jun 11 04:18 PM
JEFFS ROGERPresident & COOJun 10Sale96.2910,000962,8941,234Jun 11 04:18 PM
JEFFS ROGERPresident & COOJun 09Option Exercise30.7510,000307,50011,234Jun 09 04:14 PM
JEFFS ROGERPresident & COOJun 09Sale96.3210,000963,2001,234Jun 09 04:14 PM
CAUSEY CHRISTOPHERDirectorJun 05Option Exercise41.141,50061,7102,233Jun 05 08:42 PM
ROTHBLATT MARTINE ACEOJun 05Option Exercise32.369,066293,3835,373Jun 05 08:41 PM
DWEK RAYMONDDirectorJun 05Option Exercise30.753,00092,2503,000Jun 05 08:43 PM
Ferrari John MaximCFOJun 05Option Exercise50.0910,000500,90010,407Jun 09 04:19 PM
ROTHBLATT MARTINE ACEOJun 05Sale96.469,066874,499140Jun 05 08:41 PM
DWEK RAYMONDDirectorJun 05Sale96.743,000290,2180Jun 05 08:43 PM
CAUSEY CHRISTOPHERDirectorJun 05Sale96.481,500144,727733Jun 05 08:42 PM
Ferrari John MaximCFOJun 05Sale96.9810,000969,800407Jun 09 04:19 PM
JEFFS ROGERPresident & COOJun 03Option Exercise30.7510,000307,50011,234Jun 05 08:19 AM
JEFFS ROGERPresident & COOJun 03Sale95.0010,000950,0031,234Jun 05 08:19 AM
ROTHBLATT MARTINE ACEOMay 29Option Exercise32.369,066293,3835,373May 29 04:42 PM
ROTHBLATT MARTINE ACEOMay 29Sale95.279,066863,675140May 29 04:42 PM
JEFFS ROGERPresident & COOMay 27Option Exercise30.7510,000307,50011,234May 28 04:12 PM
JEFFS ROGERPresident & COOMay 27Sale99.1410,000991,3881,234May 28 04:12 PM
ROTHBLATT MARTINE ACEOMay 22Option Exercise32.369,066293,3835,373May 23 05:11 PM
SULLIVAN LOUIS WDirectorMay 22Option Exercise31.1730,000935,10030,000May 23 05:14 PM
ROTHBLATT MARTINE ACEOMay 22Sale101.359,066918,852140May 23 05:11 PM
SULLIVAN LOUIS WDirectorMay 22Sale101.4630,0003,043,8280May 23 05:14 PM
JEFFS ROGERPresident & COOMay 20Option Exercise30.7510,000307,50011,234May 21 04:15 PM
JEFFS ROGERPresident & COOMay 20Sale99.9110,000999,0681,234May 21 04:15 PM
JEFFS ROGERPresident & COOMay 16Option Exercise30.7510,000307,50011,234May 19 08:12 PM
JEFFS ROGERPresident & COOMay 16Sale100.0010,0001,000,0201,234May 19 08:12 PM
MAHON PAUL AEVP & General CounselMay 15Option Exercise30.756,000184,50040,832May 16 04:43 PM
ROTHBLATT MARTINE ACEOMay 15Option Exercise32.369,066293,3835,373May 16 04:45 PM
Ferrari John MaximCFOMay 15Option Exercise49.1210,000491,18810,407May 16 04:45 PM
MAHON PAUL AEVP & General CounselMay 15Sale100.866,000605,18234,832May 16 04:43 PM
ROTHBLATT MARTINE ACEOMay 15Sale100.889,066914,552140May 16 04:45 PM
Ferrari John MaximCFOMay 15Sale101.4910,0001,014,900407May 16 04:45 PM
JEFFS ROGERPresident & COOMay 13Option Exercise30.7510,000307,50011,234May 14 04:19 PM
JEFFS ROGERPresident & COOMay 13Sale105.5310,0001,055,3221,234May 14 04:19 PM
PATUSKY CHRISTOPHERDirectorMay 08Option Exercise30.755,000153,7505,000May 09 05:15 PM
ROTHBLATT MARTINE ACEOMay 08Option Exercise32.369,066293,3839,206May 09 05:27 PM
ROTHBLATT MARTINE ACEOMay 08Sale107.839,066977,598140May 09 05:27 PM
PATUSKY CHRISTOPHERDirectorMay 08Sale107.175,000535,8470May 09 05:15 PM
JEFFS ROGERPresident & COOMay 06Option Exercise30.7510,000307,50011,234May 06 07:57 PM
Thompson Tommy GDirectorMay 06Sale107.1640042,8640May 07 04:58 PM
JEFFS ROGERPresident & COOMay 06Sale106.5010,0001,065,0001,234May 06 07:57 PM
JEFFS ROGERPresident & COOMay 02Option Exercise30.7510,000307,50011,234May 02 08:03 PM
JEFFS ROGERPresident & COOMay 02Sale102.0010,0001,020,0001,234May 02 08:03 PM
Ferrari John MaximCFOMay 01Option Exercise47.5010,000475,00010,407May 01 06:58 PM
ROTHBLATT MARTINE ACEOMay 01Option Exercise32.369,066293,3835,373May 01 07:12 PM
MAHON PAUL AEVP & General CounselMay 01Option Exercise30.756,000184,50040,832May 01 07:20 PM
DWEK RAYMONDDirectorMay 01Option Exercise30.753,00092,2503,000May 01 07:25 PM
CAUSEY CHRISTOPHERDirectorMay 01Option Exercise31.171,50046,7552,233May 01 07:43 PM
Ferrari John MaximCFOMay 01Sale102.2010,0001,022,000407May 01 06:58 PM
ROTHBLATT MARTINE ACEOMay 01Sale101.849,066923,242140May 01 07:12 PM
MAHON PAUL AEVP & General CounselMay 01Sale102.716,000616,23734,832May 01 07:20 PM
DWEK RAYMONDDirectorMay 01Sale99.273,000297,8010May 01 07:25 PM
CAUSEY CHRISTOPHERDirectorMay 01Sale99.301,500148,955733May 01 07:43 PM
JEFFS ROGERPresident & COOApr 29Option Exercise30.3510,000303,53611,234Apr 30 04:24 PM
JEFFS ROGERPresident & COOApr 29Sale95.0010,000950,0001,234Apr 30 04:24 PM
ROTHBLATT MARTINE ACEOApr 24Option Exercise32.369,066293,3835,373Apr 25 06:52 PM
ROTHBLATT MARTINE ACEOApr 24Sale92.459,066838,115140Apr 25 06:52 PM
JEFFS ROGERPresident & COOApr 22Option Exercise27.9710,000279,70011,234Apr 22 07:08 PM
JEFFS ROGERPresident & COOApr 22Sale96.0010,000960,0001,234Apr 22 07:08 PM
ROTHBLATT MARTINE ACEOApr 17Option Exercise32.369,066293,3835,373Apr 18 07:58 PM
MAHON PAUL AEVP & General CounselApr 17Option Exercise30.756,000184,50040,832Apr 18 08:05 PM
ROTHBLATT MARTINE ACEOApr 17Sale98.489,066892,812140Apr 18 07:58 PM
MAHON PAUL AEVP & General CounselApr 17Sale98.376,000590,19234,832Apr 18 08:05 PM
JEFFS ROGERPresident & COOApr 15Option Exercise27.9710,000279,70011,234Apr 15 04:06 PM
JEFFS ROGERPresident & COOApr 15Sale95.0610,000950,6301,234Apr 15 04:06 PM
ROTHBLATT MARTINE ACEOApr 10Option Exercise32.369,066293,3835,373Apr 10 05:50 PM
ROTHBLATT MARTINE ACEOApr 10Sale96.189,066871,993140Apr 10 05:50 PM
JEFFS ROGERPresident & COOApr 08Option Exercise27.9710,000279,70011,234Apr 09 04:12 PM
JEFFS ROGERPresident & COOApr 08Sale95.0010,000950,0001,234Apr 09 04:12 PM
JEFFS ROGERPresident & COOApr 04Option Exercise30.7510,000307,50011,234Apr 07 04:04 PM
JEFFS ROGERPresident & COOApr 04Sale93.2210,000932,2491,234Apr 07 04:04 PM
DWEK RAYMONDDirectorApr 03Option Exercise30.753,00092,2503,000Apr 07 04:02 PM
CAUSEY CHRISTOPHERDirectorApr 03Option Exercise31.171,50046,7552,233Apr 07 04:01 PM
MAHON PAUL AEVP & General CounselApr 03Option Exercise30.756,000184,50040,832Apr 07 04:05 PM